Investment
Singapore’s Anomaly Bio secures $2.6M to revolutionize biomanufacturing
As geopolitical tensions and environmental disasters continue to destabilize global supply chains, Singapore-based biotech startup Anomaly Bio is stepping in to redesign how essential ingredients are produced with biomanufacturing. The company recently announced a successful US$2.6 million pre-seed funding round…
Investment boost for Dutch biochemical producer Mevaldi
ICOs Capital has announced an investment in Mevaldi B.V., a Dutch biotech firm specializing in sustainable biochemical building blocks. The funding aims to support Mevaldi’s efforts to increase production capacity and accelerate its commercial rollout. Alongside ICOs, High-Tech Gründerfonds and…
XCF Global evaluates financing options to drive SAF platform growth
XCF is advancing its long-term strategy by developing its SAF production platform, starting with the planned construction of New Rise Reno 2. This facility aims to expand XCF’s SAF and renewable fuel capabilities. To support this, XCF has engaged Bank…
EIB supports Aisti with €20 M loan for bio-based tiles
The European Investment Bank (EIB) has approved a €20 million loan to Aisti, a Finnish manufacturer specializing in bio-based suspended ceiling acoustic tiles. This funding aims to help Aisti increase its production capacity and accelerate its growth in sustainable building…
Black Bull Biochar raises £4 M to enter Northern Europe
Black Bull Biochar (BBB), a UK start-up focused on sustainable agriculture and carbon removal, has secured £4 million in late seed funding. The round was co-led by TSP Ventures, the Greater Manchester Combined Authority Investment Fund, and Old College Capital.…
Singapore allocates $37 B to boost bioeconomy and innovation by 2030
Singapore announced a record $37 billion investment to enhance research, innovation, and enterprise over the next five years. The focus is on transforming discoveries, especially in bioeconomy sectors, into economic growth and solutions for national challenges. The new RIE 2030…